Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

Share Price is delayed by 15 minutes
Get Live Data
6.00    -1.00 (-14.29%)
Bid:
5.50
Ask:
6.50
Spread: 1.00 (18.182%)
Market Cap: £15.44m
MAC Live PriceLast checked at - London Stock Exchange

Intraday Marechale Cap. Share Chart

Half-year Report

5 Dec 2023 07:00

Marechale Capital Plc - Half-year Report

Marechale Capital Plc - Half-year Report

PR Newswire

LONDON, United Kingdom, December 05

5 December 2023

Marechale Capital plc

("Marechale Capital", “Marechale” or the "Company")

Half-yearly Results

Marechale Capital plc, an established City of London based corporate finance house with a long-term track record and a strong reputation for advising and financing high growth consumer brands, leisure, clean energy, mineral extraction and technology companies, announces its unaudited half-yearly results for the six months ended 31 October 2023 (the “Period”).

Chairman’s Statement

Following the announcement with Marechale’s full year results released in August 2023, the market continues to remain challenging, particularly in the hospitality sector. However, the Board remains positive about the outlook for its investments.

Marechale Capital continues to see interesting corporate finance and advisory projects where it can take founders shares and warrants as part of its advisory fees. On a positive note, Marechale has completed transactions during the period for the European telecommunications technology company, Fast2fibre, Chestnut Group, the leading East Anglian Inn Group, and for Brewhouse & Kitchen, the expanding gastro pub business. However, the market remains a difficult environment in which to raise capital. This has resulted in some advisory projects that launched in the summer not being completed by the end of the Period. Marechale continues to look for new funding partners alongside its traditional investor relationships.

During the six months ended 31 October 2023, the Company generated gross profits of £93,813 (2022: £72,020) and delivered an operating loss of £155,421 (2022: loss of £178,995), resulting in an overall loss before tax of £155,803 (2022: loss of £179,502).

The Company’s balance sheet shows a net asset value of £3,340,486 (2022: £3,456,430), representing 3.15p (2022: 3.62p) of value per share in issue. The Company remains positive about the investments that it holds in its client companies. As at 31 October 2023 the Company had £400,000 of cash reserves.

The Board is working on a number of initiatives to create further value for shareholders over and above its core investment portfolio and corporate finance projects, including working with Chris Kenning, following his strategic investment of 9.9% of the Company announced in June 2023. The plan is to digitise Marechale’s activities and continue to develop strategic partnerships with the objective of enhancing shareholder value.

Marechale also uses its balance sheet to co-invest in its client companies, along with warrants and founder equity. Furthermore, the Board is hopeful to be able to announce realisations on some of the Company’s investments in the next six months

Whist the current economic climate is difficult, Marechale Capital remains diligent and is convinced that there will be good advisory and investment opportunities in its core hospitality, renewable, clean energy and technology sectors over the short to medium term.

Mark Warde-Norbury

Chairman

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014

For further information please contact:

Marechale CapitalMark Warde-Norbury / Patrick Booth-ClibbornTel: +44 (0)20 7628 5582
Cairn Financial Advisers LLPJo Turner / Sandy Jamieson Tel: +44 (0)20 7213 0880
Income Statement (unaudited)
6 months ended 31 October20232022
£
Revenue320,603168,001
Cost of sales(226,790)(95,981)
Gross profit 93,81372,020
Administrative expenses(249,235)(251,015)
Operating loss(155,421)(178,995)
Interest paid(382)(507)
(Loss/profit before tax(155,803)(179,502)
Taxation--
(Loss)/profit after tax(155,803)(179,502)
(Loss)/profit per share
(Pence)(Pence)
- Basic(0.15)(0.19)
- Diluted(0.14)(0.19)
Balance Sheet (unaudited)
As at31 October31 October
20232022
Current assets
Available for sale investments2,863,2273,116,441
Trading investments130,076146,589
Trade and other receivables37,21954,356
Cash and cash equivalents398,229246,808
3,428,7513,564,194
Current liabilities

Trade and other payables

PAYE

Bounce-back Loan

(51,278)

(9,487)

(10,000)

(59,627)

(10,638)

(10,000)

Total current liabilities(70,765)(80,265)
Net current assets3,357,9863,483,929
Bounce-back Loan – long-term(17,500)(27,500)
Net assets3,340,4863,456,429
Equity
Capital and reserves attributable to equity shareholders

Share capital

Share premium

847,530

481,290

763,023

328,413

Reserve for own shares(50,254)(50,254)
Retained profits/ (losses)1,944,8422,346,660
Reserve for share based payments117,07868,587
3,340,4863,456,429
Cash Flow Statement (unaudited)
6 months ended31 October31 October
20232022
££
Net cash from operating activities
Loss after tax (155,803)(179,502)

Provision for share based payments

Reverse interest paid

33,091

381

6,275

507

Operating cash flows before movements in working capital(122,331)(172,720)
Movement in working capital
Decrease/ (increase) in receivables38,714(10,580)
(Decrease)/ Increase in payables(30,795)12,895
Net movement in working capital7,9192,315
Operating cash out-flow(114,412)(170,405)
Investment activities
Expenditure on available for sale investments(572)-
Proceeds from sale of investments-8,750
Cash flow from investing activities(572)8,750

Financing

Share Capital

Bounce-back Loan repayments

Interest paid

Net financing

235,800

(5,000)

(381)

230,419

-

(5,000)

(507)

(5,507)

Net increase/ (decrease) in cash and cash equivalents115,435(167,162)
Cash and cash equivalents at start of the period282,794413,970
Cash and cash equivalents at end of the period398,229246,808
Increase/ (decrease) in cash and cash equivalents115,435(167,162)

This financial information has been prepared in accordance with IFRS and International Financial Reporting Interpretations Committee ('IFRIC') interpretations adopted by the European Union, and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS, with the prior period being reported on the same basis.



Date   Source Headline
21st Feb 20123:58 pmRNSHolding(s) in Company
21st Feb 20123:54 pmRNSDirector/PDMR Shareholding
21st Dec 20117:00 amRNSHalf Yearly Report
11th Nov 20113:58 pmRNSChange of Registered Office
9th Nov 20112:50 pmRNSHolding(s) in Company
22nd Sep 201111:20 amRNSResult of AGM
20th Sep 201110:03 amRNSDirector/PDMR Shareholding
25th Aug 20119:46 amRNSFinal Results
18th Apr 20111:44 pmRNSDirector/PDMR Shareholding
14th Apr 20112:16 pmRNSHolding(s) in Company
12th Apr 20117:00 amRNSDirectorate Change
31st Mar 20113:28 pmRNSIssue of Equity
29th Mar 20113:17 pmRNSDirectorate Appointment & Dealing
28th Mar 20113:39 pmRNSDirector/PDMR Shareholding
16th Mar 20119:20 amRNSDirector/PDMR Shareholding
25th Feb 20113:46 pmRNSHolding(s) in Company
9th Feb 20112:02 pmRNSDirector/PDMR Shareholding
19th Jan 20111:34 pmRNSDirector/PDMR Shareholding
13th Jan 20114:19 pmRNSHolding(s) in Company
11th Jan 201112:27 pmRNSDirector/PDMR Shareholding
15th Dec 201012:00 pmRNSHalf Yearly Report
29th Sep 20103:06 pmRNSResult of AGM
22nd Sep 201010:34 amRNSDirector/PDMR Shareholding
7th Sep 201012:00 pmRNSFinal Results and Notice of General Meeting
17th Mar 20109:00 amRNSChange of Adviser
22nd Feb 20103:15 pmRNSResult of GM
12th Feb 201012:00 pmRNSDirector/PDMR Shareholding
4th Feb 201011:00 amRNSDirector/PDMR Shareholding
29th Jan 201012:00 pmRNSNotice of General Meeting
12th Jan 20107:00 amRNSApplication for New Ordinary Shares
23rd Dec 20092:31 pmRNSHalf Yearly Report
17th Dec 20095:15 pmRNSResult of AGM
7th Dec 200912:28 pmRNSHoldings in Company / Directors Dealings
23rd Nov 20097:00 amRNSAcquisition and AGM
23rd Oct 20099:17 amRNSHolding in Company
15th Oct 20092:41 pmRNSChange of Name of Nominated Adviser and Broker
30th Sep 20094:00 pmRNSAnnual Report & Accounts
18th Sep 20097:00 amRNSNotifiable Interests
18th Sep 20097:00 amRNSHolding in Company
28th Aug 20092:30 pmRNSAcquisition of Whim Gully Capital LLP
28th Aug 20092:30 pmRNSPreliminary Results and Notice of General Meeting
21st Jul 20097:00 amRNSDisposal
6th Aug 200810:59 amRNSDirector/PDMR Shareholding
23rd Jun 20087:00 amRNSAppointment of joint broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.